Literature DB >> 26036218

Genotypes at rs2844682 and rs3909184 have no clinical value in identifying HLA-B*15:02 carriers.

Guang-Dan Zhu1, Ashley A Brenton, Alka Malhotra, Bae J Riley, Katherine E Church, Frank G Espin, Tanya A Moreno, Jennifer M Strickland, Andria L Del Tredici.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26036218     DOI： 10.1007/s00228-015-1879-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  15 in total

1.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

2.  Pharmacogenetics of drugs withdrawn from the market.

Authors:  Wei Zhang; Mary W Roederer; Wang-Qing Chen; Lan Fan; Hong-Hao Zhou
Journal:  Pharmacogenomics       Date:  2012-01       Impact factor: 2.533

3.  PharmGKB summary: carbamazepine pathway.

Authors:  Caroline F Thorn; Susan G Leckband; John Kelsoe; J Steven Leeder; Daniel J Müller; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-12       Impact factor: 2.089

4.  Screening for 392 polymorphisms in 141 pharmacogenes.

Authors:  Jason Yongha Kim; Hyun Sub Cheong; Tae-Joon Park; Hee Jung Shin; Doo Won Seo; Han Sung Na; Myeon Woo Chung; Hyoung Doo Shin
Journal:  Biomed Rep       Date:  2014-04-30

Review 5.  HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis.

Authors:  Sandeep Grover; Ritushree Kukreti
Journal:  Pharmacogenet Genomics       Date:  2014-02       Impact factor: 2.089

6.  Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.

Authors:  K E Caudle; A E Rettie; M Whirl-Carrillo; L H Smith; S Mintzer; M T M Lee; T E Klein; J T Callaghan
Journal:  Clin Pharmacol Ther       Date:  2014-08-06       Impact factor: 6.875

7.  HLA diversity in the 1000 genomes dataset.

Authors:  Pierre-Antoine Gourraud; Pouya Khankhanian; Nezih Cereb; Soo Young Yang; Michael Feolo; Martin Maiers; John D Rioux; Stephen Hauser; Jorge Oksenberg
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

Review 8.  Pharmacogenetics of antiepileptic drug-induced hypersensitivity.

Authors:  Katarzyna M Bloch; Graeme J Sills; Munir Pirmohamed; Ana Alfirevic
Journal:  Pharmacogenomics       Date:  2014-04       Impact factor: 2.533

9.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  Towards the clinical implementation of pharmacogenetics in bipolar disorder.

Authors:  Naji C Salloum; Michael J McCarthy; Susan G Leckband; John R Kelsoe
Journal:  BMC Med       Date:  2014-05-30       Impact factor: 8.775
View more
  3 in total

1.  Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.

Authors:  Ann M Moyer; Manish J Gandhi
Journal:  Methods Mol Biol       Date:  2022

2.  Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B*15:02 and HLA-A*31:01 Across Diverse Ancestral Backgrounds.

Authors:  Amanda Buchner; Xiuying Hu; Katherine J Aitchison
Journal:  Front Pharmacol       Date:  2021-07-26       Impact factor: 5.988

Review 3.  Developing pharmacogenetic screening methods for an emergent country: Vietnam.

Authors:  Dinh Van Nguyen; Christopher Vidal; Hieu Chi Chu; Sheryl van Nunen
Journal:  World Allergy Organ J       Date:  2019-06-06       Impact factor: 4.084
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.